Monopar Therapeutics Inc.
MNPR | NASDAQ
$95.49
-$0.23 (-0.24%)
Sep 22, 2026, 10:26 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -5.33B | -14.98M | -13.72M | -19.44M | -17.31M | -16.57M | -15.59M | -6.47M | -7.12M | -7.61M | -8.4M | -9.48M | -9.93M | -10.49M | -10.52M | -10.3M | -10.36M | -9.68M | -9.1M | -8.55M | -7.73M | -7.1M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 1.43B | 5.18M | 4.84M | 4.01M | 3.11M | 2.17M | 1.14M | 1.34M | 1.61M | 1.75M | 1.9M | 1.82M | 1.73M | 1.62M | 1.64M | 1.6M | 1.6M | 1.6M | 1.47M | 1.45M | 1.34M | 1.35M |
Other Working Capital | -1.77B | 321.79K | -2.99M | -737.2K | -626.99K | -488.82K | 2.98M | 28.02K | 61.73K | 8.81K | -20.41K | -21.97K | 79.31K | 128.41K | 210.98K | 163.64K | 14.45K | -12.59K | -86.2K | -2.25K | 85.59K | -13.58K |
Other Non-Cash Items | 849.72M | -1.4M | -716.46K | 4.55M | 4.55M | 4.43M | 4.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -532.32K | -191.71K | -55.41K | 242.04K | 774.36K | 311.35K | 175.05K | -122.4K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -212.61M | 1.19M | -2.61M | 47.43K | -168.78K | -441.76K | 3.49M | -813.27K | -1.31M | -1.38M | -1.35M | 53.36K | 374K | 1.89M | 2.22M | 978.4K | 1.11M | -12.59K | -456.59K | 264.33K | 330.75K | 394.73K |
Operating Cash Flow | -3.26B | -10.01M | -12.2M | -10.83M | -9.81M | -10.41M | -6.4M | -5.95M | -6.82M | -7.24M | -7.86M | -7.61M | -7.82M | -6.99M | -7.19M | -7.92M | -7.71M | -7.85M | -7.32M | -6.53M | -5.89M | -5.47M |
Capital Expenditures | -4 | -3 | -3 | -3 | -3 | -6 | -2 | -3 | -3 | -3 | -3 | -6 | -8 | -3 | -3 | 7 | 5 | 2 | 2 | -4 | n/a | 4 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -47.71B | -126.06M | -87.15M | -23.2M | -17.48M | -16.27M | -15.32M | -976.49K | -3.95M | -5.91M | -7.88M | -12.81M | -9.84M | -7.88M | -4.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 51.75B | 57.35M | 23.7M | 7.6M | 4.99M | 2.59M | 985.73K | 3.95M | 5.92M | 10.83M | 12.81M | 9.85M | 6.89M | 1.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 4.05B | -68.71M | -63.45M | -15.6M | -12.49M | -13.68M | -14.34M | 2.97M | 1.97M | 4.93M | 4.93M | -2.96M | -2.95M | -5.9M | -4.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 122.4K |
Common Stock Repurchased | -35.2M | -35.2M | -35M | -35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.67K | -24.44K | -34.42K | -58.42K | -41.75K | -33.98K | -24K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -655.64M | -1M | -1.13M | -901.19K | -536.16K | -224.53K | -104.14K | -42.51K | -34.19K | -40.88K | -46.97K | -61.29K | -27.91K | -76.79K | -59.97K | -40.33K | -65.5K | n/a | -4.02K | -11.16K | -30.07K | -13.79K |
Financial Cash Flow | -555.58M | 91.49M | 91.57M | 148.1M | 55.69M | 55.99M | 59.29M | 3.49M | 3.75M | 4.4M | 2.03M | 1.83M | 1.56M | 854.34K | 32.87K | -113.64K | -99.88K | -58.42K | 10.88M | 10.88M | 17.62M | 18.6M |
Net Cash Flow | 226.55M | 12.83M | 16.02M | 121.66M | 33.38M | 31.9M | 38.55M | 504.73K | -1.09M | 2.08M | -920.11K | -8.8M | -9.25M | -12.09M | -12.12M | -8.03M | -7.83M | -7.9M | 3.57M | 4.36M | 11.75M | 13.13M |
Free Cash Flow | -3.26B | -10.01M | -12.2M | -10.83M | -9.81M | -10.41M | -6.4M | -5.95M | -6.82M | -7.24M | -7.86M | -7.61M | -7.82M | -6.99M | -7.19M | -7.92M | -7.71M | -7.85M | -7.32M | -6.53M | -5.89M | -5.47M |
Adj. Free Cash Flow | -4.69B | -15.19M | -17.04M | -14.84M | -12.92M | -12.58M | -7.54M | -7.29M | -8.43M | -8.99M | -9.76M | -9.43M | -9.56M | -8.61M | -8.83M | -9.51M | -9.31M | -9.45M | -8.79M | -7.98M | -7.23M | -6.83M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -4 | -3 | -3 | -3 | -3 | -6 | -2 | -3 | -3 | -3 | -3 | -6 | -8 | -3 | -3 | 7 | 5 | 2 | 2 | -4 | n/a | 4 |
Owner Earnings | -3.26B | -10.01M | -12.2M | -10.83M | -9.81M | -10.41M | -6.4M | -5.95M | -6.82M | -7.24M | -7.86M | -7.61M | -7.82M | -6.99M | -7.19M | -7.92M | -7.71M | -7.85M | -7.32M | -6.53M | -5.89M | -5.47M |
Add to Watchlist
Select watchlists to add or remove MNPR